Association between the number of oocytes and cumulative live birth rate: A systematic review.
Ana Raquel Neves, Pedro Montoya-Botero, Noemie Sachs-Guedj...
https://pubmed.ncbi.nlm.nih.gov/36707342/Actively Recruiting
Led by Fundación Santiago Dexeus Font · Updated on 2026-09-08
110
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the effects of different intensities of ovarian stimulation on the number of healthy embryos in women of advanced age undergoing preimplantation genetic testing for aneuploidies PGT-A with a progestin-primed ovarian stimulation PPOS protocol. This randomized trial aims to determine if a milder stimulation approach is as effective as a more intense one in terms of embryo quality and developmental timing. Participants receive daily injections of Follitropin-delta Rekovelle starting on day 2 or 3 of their menstrual cycle. One study group receives 20 mcg per day, while the other receives 15 mcg per day. Throughout stimulation, scans and blood tests are performed on days 6, 8, and 10, and as needed until the trigger day, with doses remaining constant during the treatment period. During the study, participants are closely monitored with hormonal blood tests and ultrasound scans. Researchers will measure the number of chromosomally normal euploid embryos as the main outcome within about 20 to 30 days. Additional outcomes include hormone levels, stimulation length, embryo development timing, fertilization rates, and pregnancy rates. The entire study period lasts until the primary completion date, up to December 15, 2026.
CONDITIONS
INtensity of OVarian Stimualtion and Euploid Embryos
N
Nikolaos P Polyzos, MD, PhD
I
Ignacio Rodríguez, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Fundación Santiago Dexeus Font
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 10 to 20 days
Participants receive daily injections of Follitropin-delta starting on day 2 or 3 of their menstrual cycle. Scans and blood tests are performed on stimulation days 6, 8, 10, and as needed until the trigger day. The dose remains constant throughout stimulation.
Visits and blood tests on days 6, 8, 10, and as needed
Duration - Up to 30 days
Researchers monitor embryo development, fertilization, and pregnancy outcomes for up to about 30 days after treatment to assess the number of chromosomally normal embryos and other fertility measures.
Regular assessments during follow-up period
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Ana Raquel Neves, Pedro Montoya-Botero, Noemie Sachs-Guedj...
https://pubmed.ncbi.nlm.nih.gov/36707342/Filippo Maria Ubaldi, Danilo Cimadomo, Alberto Vaiarelli...
https://pubmed.ncbi.nlm.nih.gov/30842755/Michael M Alper, Bart C Fauser
https://pubmed.ncbi.nlm.nih.gov/28169189/Esther B Baart, Elena Martini, Marinus J Eijkemans...
https://pubmed.ncbi.nlm.nih.gov/17204525/Qianqian Wu, Hongchang Li, Yueting Zhu...
https://pubmed.ncbi.nlm.nih.gov/30137360/Joan-Carles Arce, Per Larsson, Juan Antonio García-Velasco
https://pubmed.ncbi.nlm.nih.gov/32819842/M Irani, C Canon, A Robles...
https://pubmed.ncbi.nlm.nih.gov/32348476/Christos A Venetis, Liza Tilia, Erin Panlilio...
https://pubmed.ncbi.nlm.nih.gov/30476100/Jeroen D Kok, Caspar W N Looman, Sjerp M Weima...
https://pubmed.ncbi.nlm.nih.gov/16580375/Nikolaos P Polyzos, Panagiotis Drakopoulos, Jose Parra...
https://pubmed.ncbi.nlm.nih.gov/30196963/Fundación Santiago Dexeus Font
Lead Sponsor